ARKRAY, Inc. Company Profile

21:38 EDT 20th September 2017 | BioPortfolio

News Articles [12 Associated News Articles listed on BioPortfolio]

ARKRAY launches ADAMS™ A1c HA-8180V System for hemoglobin A1c testing

EDINA, Minn., Sept. 18, 2017 /PRNewswire/ -- U.S. ARKRAY, Inc. (ARKRAY) announces the launch of the ADAMS™ A1c HA-8180V System for hemoglobin A1c testing. The system obtained FDA 510(k) clearance as...

New Blood Glucose Monitoring System Launched by ARKRAY USA

MINNEAPOLIS, Aug. 8, 2017 /PRNewswire/ -- ARKRAY USA, Inc., a leader in diabetes care products, announced today the launch of the GLUCOCARD Shine XL blood glucose monitoring system (BGMS). Highly accu...

ARKRAY USA Launches New Diabetes Management Systems for Healthcare Providers and Consumers

MINNEAPOLIS, Aug. 4, 2017 /PRNewswire/ -- ARKRAY USA, Inc., a leader in diabetes care products, announced today the launch of the ARK Care® Advance real-time diabetes management system and the A...

ARKRAY, Inc. Launches ADAMS A1c HA-8180V System For Hemoglobin A1c Testing

  Life Sciences Jobs   ...

Onsite 340B And ARKRAY USA Ink Deal To Help Covered Entities Improve Outcomes For At-Risk Population With Diabetes

  Life Sciences Jobs   ...

StoneGate Senior Living Reports Expansion of Diabetes Management Program into 41 Senior Nursing and Assisted Living Facilities throughout Texas, Oklahoma, and Colorado

The expansion, a partnership with ARKRAY USA Inc. and the Diabetes Store, supports education and improved health management for senior residents living with diabetes. Dallas, TX (PRWEB) August 30, 201...

StoneGate Senior Living Announces New Strategic Partnership with ARKRAY USA, Inc. and the Diabetes Store to Improve Quality of Life for Residents

StoneGate partnered with ARKRAY, a known expert in the field of diabetes, to bring much-needed patient education and patient self-management to one of the most prevalent chronic diseases. Dallas, TX (...

Onsite 340B and ARKRAY USA Ink Deal to Help Covered Entities Improve Outcomes for At-risk Population with Diabetes

KENNETT SQUARE, Pa., July 20, 2017 /PRNewswire/ -- Onsite 340B and ARKRAY USA announced today they are cooperating to help improve the health services for qualifying 340B program patien...

Drugs and Medications [0 Results]


PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Comparison of automated devices UX-2000 and SediMAX/AutionMax for urine samples screening: A multicenter Spanish study.

In this study we aim to compare UX2000 (Sysmex Corp, Japan) and SediMAX/AutionMax (Arkray Factory Inc., Japan), totally automatized analyzers, against Fuchs-Rosenthal counting chamber, the gold standa...

Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]


ARKRAY, the world's 5th largest manufacturer of diabetes self-monitoring systems, has been a pioneer for nearly 50 years in the field of automated analysis from laboratory and point-of-care systems to...


More Information about "ARKRAY, Inc." on BioPortfolio

We have published hundreds of ARKRAY, Inc. news stories on BioPortfolio along with dozens of ARKRAY, Inc. Clinical Trials and PubMed Articles about ARKRAY, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ARKRAY, Inc. Companies in our database. You can also find out about relevant ARKRAY, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record